SCHEMBL7147116

SCHEMBL7147116

Cc1ccc(-c2ccc3oc(CCN4CCCC4C)cc3c2)cc1C

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 20/20 0.74
KCNH2 Q12809 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2785226 1.00 HRH3 (0.74) HRH3KCNH2
SCHEMBL2786108 0.90 HRH3 (0.78) HRH3KCNH2
SCHEMBL7145740 0.89 HRH3 (0.74) HRH3KCNH2
SCHEMBL2783774 0.89 HRH3 (0.74) HRH3KCNH2
SCHEMBL2783901 0.88 HRH3 (0.77) HRH3KCNH2
SCHEMBL2786116 0.87 HRH3 (0.76) HRH3KCNH2
SCHEMBL2784160 0.87 HRH3 (0.77) HRH3KCNH2
SCHEMBL7145496 0.87 HRH3 (0.77) HRH3KCNH2
SCHEMBL2786825 0.87 HRH3 (0.77) HRH3KCNH2
SCHEMBL2786943 0.86 HRH3 (0.67) HRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370546-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS Abbott Laboratories (US) 2003-12-17 EP claimed
WO-2002074758-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LABORATORIES (US) 2002-09-26 WO claimed
EP-1370546-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS Abbott Laboratories (US) 2003-12-17 EP disclosed
WO-2002074758-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LABORATORIES (US) 2002-09-26 WO disclosed